Providing healthcare professionals a reliable and rapid test result is lifesaving for many patients. From single test, rapid lateral flow assays (LFA) to high- ...
Missing: investor relations
Information on valuation, funding, cap tables, investors, and executives for Immy. Use the PitchBook Platform to explore the full profile.
Missing: relations | Show results with:relations
40 YEARS OF DEVELOPMENT. IMMY manufactures, markets, and distributes innovative lines of diagnostic tests and reagents for infectious diseases.
Missing: investor relations
Feb 16, 2017 · The following slide deck was published by Imprimis Pharmaceuticals, Inc.
Missing: relations | Show results with:relations
Retune your immune system with ancient (friendly) bacteria. Meet immy, a ground-breaking supplement derived from a naturally occurring strain of bacteria that ...
Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Imprimis Pharmaceuticals, Inc. (IMMY) using our online tools.
Experience · Senior Financial Analyst, Investor Relations · Private Investor - Micro-Cap and Small-Cap · Investment Assistant to Chairman · Research Analyst.
Missing: immy | Show results with:immy
People also ask
Who is the CEO of Immy com?
(Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product ...
Missing: immy | Show results with:immy
(NASDAQ: IMMY), an ophthalmology-focused ... To listen to the webcast, please click here or visit the investor relations section of the Imprimis website at www.
(NASDAQ: IMMY), a pharmaceutical company focused ... Boll will continue to oversee accounting and financial reporting, investor relations, human resources and ...